Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shehla Shaikh

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Advances in Therapy|December 5, 2024
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized TrialAwadhesh Kumar Singh, Ashok Kumar Das, L Sreenivasa Murthy, et al.
Diabetes Research and Clinical Practice|January 25, 2021
The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetesMohamed Hassanein, Zanariah Hussein, Inass Shaltout, et al.
Cureus|July 31, 2025
Expert Consensus Statement on Simplified Glycemic Care in Patients With Type 2 Diabetes MellitusBipin Sethi, Subhankar Chowdhury, Sunil M Jain, et al.
Diabetes & Metabolic Syndrome|June 10, 2023
Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global surveyMohamed Hassanein, Sanobia Yousuf, Muhammad Yakoob Ahmedani, et al.
The Journal of the Association of Physicians of India|May 13, 2024
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and ConsensusAwadhesh Kumar Singh, Anoop Misra, Ashok Kumar Das, et al.
Cardiovascular Diabetology. Endocrinology Reports|April 23, 2026
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)Nitin Kapoor, Shehla Shaikh, Saptarshi Bhattacharya, et al.
Diabetes & Metabolic Syndrome|December 14, 2020
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinionAshok Kumar Das, Sanjay Kalra, Krishnakumar B, et al.
Cureus|March 26, 2026
Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study)Nitin Kapoor, Sanjay Kalra, Arindam Naskar, et al.
The Review of Diabetic Studies : RDS|July 14, 2022
Asian Best Practices for Care of Diabetes in Elderly (ABCDE)Sanjay Kalra, Minakshi Dhar, Faria Afsana, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 26, 2020
A Practitioner's Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert PanelSanjay Kalra, Sarita Bajaj, Surendra Kumar Sharma, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Advances in Therapy|December 5, 2024
Efficacy of Dapagliflozin + Sitagliptin + Metformin Versus Sitagliptin + Metformin in T2DM Inadequately Controlled on Metformin Monotherapy: A Multicentric Randomized TrialAwadhesh Kumar Singh, Ashok Kumar Das, L Sreenivasa Murthy, et al.
Diabetes Research and Clinical Practice|January 25, 2021
The DAR 2020 Global survey: Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetesMohamed Hassanein, Zanariah Hussein, Inass Shaltout, et al.
Cureus|July 31, 2025
Expert Consensus Statement on Simplified Glycemic Care in Patients With Type 2 Diabetes MellitusBipin Sethi, Subhankar Chowdhury, Sunil M Jain, et al.
Diabetes & Metabolic Syndrome|June 10, 2023
Ramadan fasting in people with diabetes and chronic kidney disease (CKD) during the COVID-19 pandemic: The DaR global surveyMohamed Hassanein, Sanobia Yousuf, Muhammad Yakoob Ahmedani, et al.
The Journal of the Association of Physicians of India|May 13, 2024
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and ConsensusAwadhesh Kumar Singh, Anoop Misra, Ashok Kumar Das, et al.
Cardiovascular Diabetology. Endocrinology Reports|April 23, 2026
Efficacy and safety of semaglutide injection in Indian patients with type 2 diabetes mellitus inadequately controlled on metformin: a phase 3, randomized, active-controlled trial (SIZE-DM study)Nitin Kapoor, Shehla Shaikh, Saptarshi Bhattacharya, et al.
Diabetes & Metabolic Syndrome|December 14, 2020
Cardiometabolic vigilance in COVID-19 and resource husbandry in resource-challenged times: Clinical practice- based expert opinionAshok Kumar Das, Sanjay Kalra, Krishnakumar B, et al.
Cureus|March 26, 2026
Comparative Efficacy and Safety of Once-Weekly Semaglutide Formulations in Indian Adults With Obesity: A Phase III, Randomized Non-inferiority Active-Controlled Study (Size Plus Study)Nitin Kapoor, Sanjay Kalra, Arindam Naskar, et al.
The Review of Diabetic Studies : RDS|July 14, 2022
Asian Best Practices for Care of Diabetes in Elderly (ABCDE)Sanjay Kalra, Minakshi Dhar, Faria Afsana, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|January 26, 2020
A Practitioner's Toolkit for Insulin Motivation in Adults with Type 1 and Type 2 Diabetes Mellitus: Evidence-Based Recommendations from an International Expert PanelSanjay Kalra, Sarita Bajaj, Surendra Kumar Sharma, et al.
Pageof 6